The global liquid embolic agent market was valued at USD 243.90 million in 2024 and is expected to grow at a compound annual growth rate of 9.7 percent from 2025 to 2034. Backed by robust demand for less invasive vascular therapies and increasing prevalence of neurovascular and oncology-related vascular conditions, the market forecast is firmly data-anchored. In 2024, North America emerged as...
The U.S. liquid embolic agent market size was valued at USD 66.28 million in 2024, with projections indicating a CAGR of 9.0% between 2025 and 2034, underscoring the accelerating adoption of minimally invasive procedures in interventional neurology and oncology. While the U.S. remains the most mature and revenue-dominant market, the growth trajectory of liquid embolic agents is shaped not only...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek